Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 2107763)

1.

Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: a naturalistic study.

Strober M, Morrell W, Lampert C, Burroughs J.

Am J Psychiatry. 1990 Apr;147(4):457-61.

PMID:
2107763
2.

A case with reversible neurotoxicity after 2 years of dementia secondary to maintenance lithium treatment.

Soriano-Barceló J, Alonso MT, Traba MB, Vilar AA, Kahn DA.

J Psychiatr Pract. 2015 Mar;21(2):154-9. doi: 10.1097/01.pra.0000462608.02478.16.

PMID:
25782766
3.

A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients.

Simhandl C, König B, Amann BL.

J Clin Psychiatry. 2014 Mar;75(3):254-62; quiz 263. doi: 10.4088/JCP.13m08601.

PMID:
24717379
4.

Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.

Cipriani A, Reid K, Young AH, Macritchie K, Geddes J.

Cochrane Database Syst Rev. 2013 Oct 17;10:CD003196. doi: 10.1002/14651858.CD003196.pub2. Review.

PMID:
24132760
5.

[Long-term treatment of bipolar disorder: how should we use lithium salts?].

Del Grande C, Muti M, Musetti L, Pergentini I, Corsi M, Turri M, Soldani I, Corsini GU, Dell'Osso L.

Riv Psichiatr. 2012 Nov-Dec;47(6):515-26. doi: 10.1708/1178.13058. Italian.

PMID:
23160112
6.

Characterizing relapse prevention in bipolar disorder with adjunctive ziprasidone: clinical and methodological implications.

Bowden CL, Karayal ON, Schwartz JH, Gundapaneni BK, O'Gorman C.

J Affect Disord. 2013 Jan 10;144(1-2):171-5. doi: 10.1016/j.jad.2012.04.024. Epub 2012 Sep 21.

PMID:
22999893
7.

Variables as mediators or moderators in predicting relapse to any type of mood episode in a bipolar maintenance study.

Tohen M, Wang WV, Leboyer M, Jen KY.

J Clin Psychiatry. 2012 Jul;73(7):e913-7. doi: 10.4088/JCP.10m06737.

PMID:
22901362
8.

A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents.

Geller B, Luby JL, Joshi P, Wagner KD, Emslie G, Walkup JT, Axelson DA, Bolhofner K, Robb A, Wolf DV, Riddle MA, Birmaher B, Nusrat N, Ryan ND, Vitiello B, Tillman R, Lavori P.

Arch Gen Psychiatry. 2012 May;69(5):515-28. doi: 10.1001/archgenpsychiatry.2011.1508. Epub 2012 Jan 2.

9.

Predictors of relapse or recurrence in bipolar I disorder.

Degenhardt EK, Gatz JL, Jacob J, Tohen M.

J Affect Disord. 2012 Feb;136(3):733-9. doi: 10.1016/j.jad.2011.09.051. Epub 2011 Oct 28.

PMID:
22036802
10.

Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder.

Post RM, Altshuler LL, Frye MA, Suppes T, Keck PE Jr, McElroy SL, Leverich GS, Luckenbaugh DA, Rowe M, Pizzarello S, Kupka RW, Grunze H, Nolen WA.

J Clin Psychiatry. 2010 Sep;71(9):1176-86; quiz 1252-3. doi: 10.4088/JCP.08m04811yel.

PMID:
20923622
11.

Influence of atypical features on the quality of prophylactic effectiveness of long-term lithium treatment in bipolar disorders.

Pfennig A, Schlattmann P, Alda M, Grof P, Glenn T, Müller-Oerlinghausen B, Suwalska A, Rybakowski J, Willich SN, Bauer M, Berghöfer A.

Bipolar Disord. 2010 Jun;12(4):390-6. doi: 10.1111/j.1399-5618.2010.00826.x.

PMID:
20636636
12.

Long-term effectiveness of lithium in bipolar disorder: a multicenter investigation of patients with typical and atypical features.

Berghöfer A, Alda M, Adli M, Baethge C, Bauer M, Bschor T, Glenn T, Grof P, Müller-Oerlinghausen B, Rybakowski J, Suwalska A, Pfennig A.

J Clin Psychiatry. 2008 Dec;69(12):1860-8. Epub 2008 Nov 18.

PMID:
19026269
13.

Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.

Severus WE, Kleindienst N, Evoniuk G, Bowden C, Möller HJ, Bohus M, Frangou S, Greil W, Calabrese JR.

J Affect Disord. 2009 Jun;115(3):466-70. doi: 10.1016/j.jad.2008.10.009. Epub 2008 Nov 20.

PMID:
19019453
14.

[Predictors of prophylactic response to lithium].

Rohayem J, Baylé JF, Richa S.

Encephale. 2008 Sep;34(4):394-9. doi: 10.1016/j.encep.2007.05.002. Epub 2007 Nov 26. Review. French.

PMID:
18922242
15.

Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation.

Viguera AC, Whitfield T, Baldessarini RJ, Newport DJ, Stowe Z, Reminick A, Zurick A, Cohen LS.

Am J Psychiatry. 2007 Dec;164(12):1817-24; quiz 1923.

PMID:
18056236
16.

A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.

Soares-Weiser K, Bravo Vergel Y, Beynon S, Dunn G, Barbieri M, Duffy S, Geddes J, Gilbody S, Palmer S, Woolacott N.

Health Technol Assess. 2007 Oct;11(39):iii-iv, ix-206. Review.

17.

Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study.

Biel MG, Peselow E, Mulcare L, Case BG, Fieve R.

Bipolar Disord. 2007 Aug;9(5):435-42.

PMID:
17680913
18.

Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.

Ketter TA, Houston JP, Adams DH, Risser RC, Meyers AL, Williamson DJ, Tohen M.

J Clin Psychiatry. 2006 Jan;67(1):95-101.

PMID:
16426094
19.

A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder.

Calabrese JR, Shelton MD, Rapport DJ, Youngstrom EA, Jackson K, Bilali S, Ganocy SJ, Findling RL.

Am J Psychiatry. 2005 Nov;162(11):2152-61.

PMID:
16263857
20.

Initial symptoms of manic relapse in manic or mixed-manic bipolar disorder: post hoc analysis of patients treated with olanzapine or lithium.

Houston JP, Lipkovich IA, Ahl J, Rotelli MD, Baker RW, Bowden CL.

J Psychiatr Res. 2007 Oct;41(7):616-21. Epub 2005 Oct 17.

PMID:
16236320
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk